Abstract

With an ever increasing demand to quickly deliver samples to scientists for pharmaceutical research, Compound Management groups around the world constantly re-evaluate their operating model, through a balancing act between investment in new technologies and people, and the constraints of physical lab footprint.We believe that Autonomous Mobile Robotics (AMR) are the next frontier in cutting edge pharmaceutical R&D, a technology that has the potential to deliver a disruptive change that allows the growth required while working within tight budgetary and real estate constraints.Here we share our vision, reimagining our current workflows in a world when AMR will connect equipment within the current lab footprint, and make better use of existing resources, helping us meet the current and future demand.